C. Roozendaal et al., CATALASE AND ALPHA-ENOLASE - 2 NOVEL GRANULOCYTE AUTOANTIGENS IN INFLAMMATORY BOWEL-DISEASE (IBD), Clinical and experimental immunology, 112(1), 1998, pp. 10-16
In IBD, the target antigens of anti-neutrophil cytoplasmic autoantibod
ies (ANCA) have not been fully identified, which limits the analysis o
f the diagnostic significance as well as of the possible pathophysiolo
gical role of these antibodies. In this study, we identify the target
antigens of ANCA in large groups of patients with ulcerative colitis (
UC) and Crohn's disease (CD). Apart from antibodies against lactoferri
n and bactericidal/permeability-increasing protein (BPI), which have b
een reported before, antibodies against two novel granulocyte antigens
were identified: antibodies against a 57/56-kD doublet were found in
38% of samples from UC patients and in 26% of samples from CD patients
, whereas antibodies against a 47-kD protein were found in 10% of samp
les from UC patients and in 18% of samples from CD patients. Partial p
urification and amino acid sequence analysis identified the 57-kD prot
ein as catalase and the 47-kD protein as alpha-enolase. This study is
the first to report catalase and alpha-enolase as granulocyte antigens
for autoantibodies in IBD.